{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T15:27:03Z","timestamp":1791905223004,"version":"4.3.4"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["91332201, 81071019, 81500907, 31471027"],"award-info":[{"award-number":["91332201, 81071019, 81500907, 31471027"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the National Key Research and Development Program Foundation of China","award":["2016YFC1306403"],"award-info":[{"award-number":["2016YFC1306403"]}]},{"name":"the Natural Science Foundation of Shanghai","award":["13JC1401501"],"award-info":[{"award-number":["13JC1401501"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13195-018-0354-2","type":"journal-article","created":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T19:59:35Z","timestamp":1519847975000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["Thiamine diphosphate reduction strongly correlates with brain glucose hypometabolism in Alzheimer\u2019s disease, whereas amyloid deposition does not"],"prefix":"10.1186","volume":"10","author":[{"given":"Shaoming","family":"Sang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoli","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lirong","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqiang","family":"Fei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changpeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhua","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyang","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqi","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiyan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihui","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongcheng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7870-3441","authenticated-orcid":false,"given":"Chunjiu","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,1]]},"reference":[{"key":"354_CR1","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/j.jalz.2016.03.001","volume":"12","author":"Alzheimer\u2019s Association","year":"2016","unstructured":"Alzheimer\u2019s Association. 2016 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2016;12:459\u2013509.","journal-title":"Alzheimers Dement."},{"key":"354_CR2","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science. 2002;297:353\u20136.","journal-title":"Science."},{"key":"354_CR3","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA. Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science. 1992;256:184\u20135.","journal-title":"Science."},{"key":"354_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.pneurobio.2013.06.004","volume":"108","author":"Z Chen","year":"2013","unstructured":"Chen Z, Zhong C. Decoding Alzheimer\u2019s disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies. Prog Neurobiol. 2013;108:21\u201343.","journal-title":"Prog Neurobiol."},{"key":"354_CR5","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/nn.4018","volume":"18","author":"ES Musiek","year":"2015","unstructured":"Musiek ES, Holtzman DM. Three dimensions of the amyloid hypothesis: time, space and \u2018wingmen\u2019. Nat Neurosci. 2015;18:800\u20136.","journal-title":"Nat Neurosci."},{"key":"354_CR6","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/nn.4017","volume":"18","author":"K Herrup","year":"2015","unstructured":"Herrup K. The case for rejecting the amyloid cascade hypothesis. Nat Neurosci. 2015;18:794\u20139.","journal-title":"Nat Neurosci."},{"key":"354_CR7","doi-asserted-by":"publisher","first-page":"3734","DOI":"10.1093\/brain\/awv278","volume":"138","author":"A Altmann","year":"2015","unstructured":"Altmann A, Ng B, Landau SM, Jagust WJ, Greicius MD. Regional brain hypometabolism is unrelated to regional amyloid plaque burden. Brain. 2015;138:3734\u201346.","journal-title":"Brain."},{"key":"354_CR8","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1016\/j.jalz.2014.03.006","volume":"10","author":"P Alexopoulos","year":"2014","unstructured":"Alexopoulos P, Kriett L, Haller B, Klupp E, Gray K, Grimmer T, Laskaris N, F\u00f6rster S, Perneczky R, Kurz A, Drzezga A, Fellgiebel A, Yakushev I. Limited agreement between biomarkers of neuronal injury at different stages of Alzheimer\u2019s disease. Alzheimers Dement. 2014;10:684\u20139.","journal-title":"Alzheimers Dement."},{"key":"354_CR9","first-page":"1512","volume":"70","author":"M Wirth","year":"2013","unstructured":"Wirth M, Villeneuve S, Haase CM, Madison CM, Oh H, Landau SM, Rabinovici GD, Jagust WJ. Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people. JAMA Neurol. 2013;70:1512\u20139.","journal-title":"JAMA Neurol."},{"key":"354_CR10","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1002\/ana.23816","volume":"73","author":"DS Knopman","year":"2013","unstructured":"Knopman DS, Jack CR Jr, Wiste HJ, Weigand SD, Vemuri P, Lowe VJ, Kantarci K, Gunter JL, Senjem ML, Mielke MM, Roberts RO, Boeve BF, Petersen RC. Brain injury biomarkers are not dependent on \u03b2-amyloid in normal elderly. Ann Neurol. 2013;73:472\u201380.","journal-title":"Ann Neurol."},{"key":"354_CR11","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1093\/brain\/aws327","volume":"136","author":"M Lehmann","year":"2013","unstructured":"Lehmann M, Ghosh PM, Madison C, Laforce R, Corbetta-Rastelli C, Weiner MW, Greicius MD, Seeley WW, Gorno-Tempini ML, Rosen HJ, Miller BL, Jagust WJ, Rabinovici GD. Diverging patterns of amyloid deposition and hypometabolism in clinical variants of probable Alzheimer\u2019s disease. Brain. 2013;136:844\u201358.","journal-title":"Brain."},{"key":"354_CR12","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1056\/NEJM199603213341202","volume":"334","author":"EM Reiman","year":"1996","unstructured":"Reiman EM, Caselli RJ, Yun LS, Chen K, Bandy D, Minoshima S, Thibodeau SN, Osborne D. Preclinical evidence of Alzheimer\u2019s disease in persons homozygous for the \u03b54 allele for apolipoprotein E. N Engl J Med. 1996;334:752\u20138.","journal-title":"N Engl J Med."},{"key":"354_CR13","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/s00259-005-1762-7","volume":"32","author":"L Mosconi","year":"2005","unstructured":"Mosconi L. Brain glucose metabolism in the early and specific diagnosis of Alzheimer\u2019s disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging. 2005;32:486\u2013510.","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"354_CR14","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1212\/01.wnl.0000244749.20056.d4","volume":"68","author":"P Edison","year":"2007","unstructured":"Edison P, Archer HA, Hinz R, Hammers A, Pavese N, Tai YF, Hotton G, Cutler D, Fox N, Kennedy A, Rossor M, Brooks DJ. Amyloid, hypometabolism, and cognition in Alzheimer disease: an [11C]PIB and [18F]FDG PET study. Neurology. 2007;68:501\u20138.","journal-title":"Neurology."},{"key":"354_CR15","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nrn4019","volume":"16","author":"GJ Biessels","year":"2015","unstructured":"Biessels GJ, Reagan LP. Hippocampal insulin resistance and cognitive dysfunction. Nat Rev Neurosci. 2015;16:660\u201371.","journal-title":"Nat Rev Neurosci."},{"key":"354_CR16","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1001\/archneurol.2011.233","volume":"69","author":"S Craft","year":"2012","unstructured":"Craft S, Baker LD, Montine TJ, Minoshima S, Watson GS, Claxton A, Arbuckle M, Callaghan M, Tsai E, Plymate SR, Green PS, Leverenz J, Cross D, Gerton B. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol. 2012;69:29\u201338.","journal-title":"Arch Neurol."},{"key":"354_CR17","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1001\/archneur.1988.00520320022009","volume":"45","author":"GE Gibson","year":"1988","unstructured":"Gibson GE, Sheu KF, Blass JP, Baker A, Carlson KC, Harding B, Perrino P. Reduced activities of thiamine-dependent enzymes in the brains and peripheral tissues of patients with Alzheimer\u2019s disease. Arch Neurol. 1988;45:836\u201340.","journal-title":"Arch Neurol."},{"key":"354_CR18","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/ana.410390507","volume":"39","author":"F Mastrogiacoma","year":"1996","unstructured":"Mastrogiacoma F, Bettendorff L, Grisar T, Kish SJ. Brain thiamine, its phosphate esters, and its metabolizing enzymes in Alzheimer\u2019s disease. Ann Neurol. 1996;39:585\u201391.","journal-title":"Ann Neurol."},{"key":"354_CR19","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1023\/A:1020678912330","volume":"13","author":"M Gold","year":"1998","unstructured":"Gold M, Hauser RA, Chen MF. Plasma thiamine deficiency associated with Alzheimer\u2019s disease but not Parkinson\u2019s disease. Metab Brain Dis. 1998;13:43\u201353.","journal-title":"Metab Brain Dis."},{"key":"354_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/BF02080933","volume":"11","author":"M Heroux","year":"1996","unstructured":"Heroux M, Raghavendra RV, Lavoie J, Richardson JS, Butterworth RF. Alterations of thiamine phosphorylation and of thiamine-dependent enzymes in Alzheimer\u2019s disease. Metab Brain Dis. 1996;11:81\u20138.","journal-title":"Metab Brain Dis."},{"key":"354_CR21","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.ebiom.2015.11.039","volume":"3","author":"X Pan","year":"2016","unstructured":"Pan X, Fei G, Lu J, Jin L, Pan S, Chen Z, Wang C, Sang S, Liu H, Hu W, Zhang H, Wang H, Wang Z, Tan Q, Qin Y, Zhang Q, Xie X, Ji Y, Cui D, Gu X, Xu J, Yu Y, Zhong C. Measurement of blood thiamine metabolites for Alzheimer\u2019s disease diagnosis. EBioMedicine. 2016;3:155\u201362.","journal-title":"EBioMedicine."},{"key":"354_CR22","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","volume":"7","author":"GM McKhann","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CJ, Kawas CH, Klunk WE, Koroshetz WJ, Manly JJ, Mayeux R, Mohs RC, Morris JC, Rossor MN, Scheltens P, Carrillo MC, Thies B, Weintraub S, Phelps CH. The diagnosis of dementia due to Alzheimer\u2019s disease: recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease. Alzheimers Dement. 2011;7:263\u20139.","journal-title":"Alzheimers Dement."},{"key":"354_CR23","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/j.neuroimage.2016.09.031","volume":"146","author":"H Zhang","year":"2017","unstructured":"Zhang H, Wu P, Ziegler SI, Guan Y, Wang Y, Ge J, Schwaiger M, Huang SC, Zuo C, Forster S, Shi K. Data-driven identification of intensity normalization region based on longitudinal coherency of 18F-FDG metabolism in the healthy brain. Neuroimage. 2017;146:589\u201399.","journal-title":"Neuroimage."},{"key":"354_CR24","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.neuroimage.2013.01.015","volume":"71","author":"AD Cohen","year":"2013","unstructured":"Cohen AD, Mowrey W, Weissfeld LA, Aizenstein HJ, McDade E, Mountz JM, Nebes RD, Saxton JA, Snitz B, DeKosky S, Williamson J, Lopez OL, Price JC, Mathis CA, Klunk WE. Classification of amyloid-positivity in controls: comparison of visual read and quantitative approaches. Neuroimage. 2013;71:207\u201315.","journal-title":"Neuroimage."},{"key":"354_CR25","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1021\/acs.jmedchem.6b01328","volume":"60","author":"C Wu","year":"2017","unstructured":"Wu C, Eck B, Zhang S, Zhu J, Tiwari AD, Zhang Y, Zhu Y, Zhang J, Wang B, Wang X, Wang X, You J, Wang J, Guan Y, Liu X, Yu X, Trapp BD, Miller R, Silver J, Wilson D, Wang Y. Discovery of 1,2,3-triazole derivatives for multimodality PET\/CT\/cryoimaging of myelination in the central nervous system. J Med Chem. 2017;60:987\u201399.","journal-title":"J Med Chem."},{"key":"354_CR26","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1093\/brain\/awq069","volume":"133","author":"X Pan","year":"2010","unstructured":"Pan X, Gong N, Zhao J, Yu Z, Gu F, Chen J, Sun X, Zhao L, Yu M, Xu Z, Dong W, Qin Y, Fei G, Zhong C, Xu TL. Powerful beneficial effects of benfotiamine on cognitive impairment and \u03b2-amyloid deposition in amyloid precursor protein\/presenilin-1 transgenic mice. Brain. 2010;133:1342\u201351.","journal-title":"Brain."},{"key":"354_CR27","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s12640-010-9204-0","volume":"19","author":"J Zhao","year":"2011","unstructured":"Zhao J, Sun X, Yu Z, Pan X, Gu F, Chen J, Dong W, Zhao L, Zhong C. Exposure to pyrithiamine increases \u03b2-amyloid accumulation, Tau hyperphosphorylation, and glycogen synthase kinase-3 activity in the brain. Neurotox Res. 2011;19:575\u201383.","journal-title":"Neurotox Res."},{"key":"354_CR28","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.neurobiolaging.2009.01.005","volume":"32","author":"Q Zhang","year":"2011","unstructured":"Zhang Q, Yang G, Li W, Fan Z, Sun A, Luo J, Ke ZJ. Thiamine deficiency increases \u03b2-secretase activity and accumulation of \u03b2-amyloid peptides. Neurobiol Aging. 2011;32:42\u201353.","journal-title":"Neurobiol Aging."},{"key":"354_CR29","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1016\/j.neurobiolaging.2007.12.013","volume":"30","author":"SS Karuppagounder","year":"2009","unstructured":"Karuppagounder SS, Xu H, Shi Q, Chen LH, Pedrini S, Pechman D, Baker H, Beal MF, Gandy SE, Gibson GE. Thiamine deficiency induces oxidative stress and exacerbates the plaque pathology in Alzheimer\u2019s mouse model. Neurobiol Aging. 2009;30:1587\u2013600.","journal-title":"Neurobiol Aging."},{"key":"354_CR30","doi-asserted-by":"publisher","first-page":"6412","DOI":"10.1111\/febs.12512","volume":"280","author":"VI Bunik","year":"2013","unstructured":"Bunik VI, Tylicki A, Lukashev NV. Thiamin diphosphate-dependent enzymes: from enzymology to metabolic regulation, drug design and disease models. FEBS J. 2013;280:6412\u201342.","journal-title":"FEBS J."},{"key":"354_CR31","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1002\/ana.23955","volume":"74","author":"P Podlesniy","year":"2013","unstructured":"Podlesniy P, Figueiro-Silva J, Llado A, Antonell A, Sanchez-Valle R, Alcolea D, Lleo A, Molinuevo JL, Serra N, Trullas R. Low cerebrospinal fluid concentration of mitochondrial DNA in preclinical Alzheimer disease. Ann Neurol. 2013;74:655\u201368.","journal-title":"Ann Neurol."},{"key":"354_CR32","doi-asserted-by":"crossref","first-page":"685","DOI":"10.3233\/JAD-2012-111592","volume":"30","author":"K Lunnon","year":"2012","unstructured":"Lunnon K, Ibrahim Z, Proitsi P, Lourdusamy A, Newhouse S, Sattlecker M, Furney S, Saleem M, Soininen H, Kloszewska I, Mecocci P, Tsolaki M, Vellas B, Coppola G, Geschwind D, Simmons A, Lovestone S, Dobson R, Hodges A. Mitochondrial dysfunction and immune activation are detectable in early Alzheimer\u2019s disease blood. J Alzheimers Dis. 2012;30:685\u2013710.","journal-title":"J Alzheimers Dis."},{"key":"354_CR33","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1312889","volume":"370","author":"RS Doody","year":"2014","unstructured":"Doody RS, Thomas RG, Farlow M, Iwatsubo T, Vellas B, Joffe S, Kieburtz K, Raman R, Sun X, Aisen PS, Siemers E, Liu-Seifert H, Mohs R. Phase 3 trials of solanezumab for mild-to-moderate Alzheimer\u2019s disease. N Engl J Med. 2014;370:311\u201321.","journal-title":"N Engl J Med."},{"key":"354_CR34","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1056\/NEJMoa1304839","volume":"370","author":"S Salloway","year":"2014","unstructured":"Salloway S, Sperling R, Fox NC, Blennow K, Klunk W, Raskind M, Sabbagh M, Honig LS, Porsteinsson AP, Ferris S, Reichert M, Ketter N, Nejadnik B, Guenzler V, Miloslavsky M, Wang D, Lu Y, Lull J, Tudor IC, Liu E, Grundman M, Yuen E, Black R, Brashear HR. Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer\u2019s disease. N Engl J Med. 2014;370:322\u201333.","journal-title":"N Engl J Med."},{"key":"354_CR35","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/S0140-6736(08)61075-2","volume":"372","author":"C Holmes","year":"2008","unstructured":"Holmes C, Boche D, Wilkinson D, Yadegarfar G, Hopkins V, Bayer A, Jones RW, Bullock R, Love S, Neal JW, Zotova E, Nicoll JA. Long-term effects of A\u03b242 immunisation in Alzheimer\u2019s disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet. 2008;372:216\u201323.","journal-title":"Lancet."},{"key":"354_CR36","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1016\/S0140-6736(16)31275-2","volume":"388","author":"S Gauthier","year":"2016","unstructured":"Gauthier S, Feldman HH, Schneider LS, Wilcock GK, Frisoni GB, Hardlund JH, Moebius HJ, Bentham P, Kook KA, Wischik DJ, Schelter BO, Davis CS, Staff RT, Bracoud L, Shamsi K, Storey JMD, Harrington CR, Wischik CM. Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer\u2019s disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial. Lancet. 2016;388:2873\u201384.","journal-title":"Lancet."},{"key":"354_CR37","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1038\/nm834","volume":"9","author":"HP Hammes","year":"2003","unstructured":"Hammes HP, Du X, Edelstein D, Taguchi T, Matsumura T, Ju Q, Lin J, Bierhaus A, Nawroth P, Hannak D, Neumaier M, Bergfeld R, Giardino I, Brownlee M. Benfotiamine blocks three major pathways of hyperglycemic damage and prevents experimental diabetic retinopathy. Nat Med. 2003;9:294\u20139.","journal-title":"Nat Med."},{"key":"354_CR38","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/jcph.261","volume":"54","author":"F Xie","year":"2014","unstructured":"Xie F, Cheng Z, Li S, Liu X, Guo X, Yu P, Gu Z. Pharmacokinetic study of benfotiamine and the bioavailability assessment compared to thiamine hydrochloride. J Clin Pharmacol. 2014;54:688\u201395.","journal-title":"J Clin Pharmacol."},{"key":"354_CR39","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s12264-016-0067-0","volume":"32","author":"X Pan","year":"2016","unstructured":"Pan X, Chen Z, Fei G, Pan S, Bao W, Ren S, Guan Y, Zhong C. Long-term cognitive improvement after benfotiamine administration in patients with Alzheimer\u2019s disease. Neurosci Bull. 2016;32:591\u20136.","journal-title":"Neurosci Bull."},{"key":"354_CR40","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1202753","volume":"367","author":"RJ Bateman","year":"2012","unstructured":"Bateman RJ, Xiong C, Benzinger TLS, Fagan AM, Goate A, Fox NC, Marcus DS, Cairns NJ, Xie X, Blazey TM, Holtzman DM, Santacruz A, Buckles V, Oliver A, Moulder K, Aisen PS, Ghetti B, Klunk WE, McDade E, Martins RN, Masters CL, Mayeux R, Ringman JM, Rossor MN, Schofield PR, Sperling RA, Salloway S, Morris JC. Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease. N Engl J Med. 2012;367:795\u2013804.","journal-title":"N Engl J Med."},{"key":"354_CR41","doi-asserted-by":"publisher","first-page":"e0167273","DOI":"10.1371\/journal.pone.0167273","volume":"12","author":"X Pan","year":"2017","unstructured":"Pan X, Sang S, Fei G, Jin L, Liu H, Wang Z, Wang H, Zhong C. Enhanced activities of blood thiamine diphosphatase and monophosphatase in Alzheimer\u2019s disease. PLoS One. 2017;12:e0167273.","journal-title":"PLoS One."}],"container-title":["Alzheimer's Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-018-0354-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,28]],"date-time":"2019-02-28T20:32:59Z","timestamp":1551385979000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-018-0354-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["354"],"URL":"https:\/\/doi.org\/10.1186\/s13195-018-0354-2","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,1]]},"assertion":[{"value":"26 July 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Committee of Medical Ethics of Zhongshan Hospital, Fudan University. All animal care and experimental procedures were approved by the Medical Experimental Animal Administrative Committee of Fudan University and by the Institutional Animals Care and Use Committee of the Institute of Neuroscience, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences. Informed consent was obtained from all participating subjects.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"CJZ holds shares of Shanghai Rixin Bitech Co., Ltd., which is dedicated to developing drugs for preventing and treating AD. The other authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"26"}}